Position in GLUE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$977,098
+$577,052 QoQ
Shares Held
40,376
+66.0% QoQ
Ownership
0.047%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#96
of 193 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GLUE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Legal & General Group Plc holds $3,286,710,193 across 292 Biotechnology names. GLUE ranks #112 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,870,015 | $928,892,550 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
759,971 | $473,872,316 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
924,561 | $278,320,596 | |
| 4 | RPRX |
Royalty Pharma plc
|
3,800,504 | $213,094,258 | |
| 5 | INCY |
Incyte Corp
|
1,605,980 | $182,053,892 | |
| 6 | ARGX |
Argenx SE
|
177,164 | $164,367,443 | |
| 7 | INSM |
INSMED Inc
|
826,431 | $88,114,072 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
381,366 | $71,422,223 |
All Filings in GLUE
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $977,098 | 40,376 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $400,046 | 24,319 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $66,561 | 4,245 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $31,455 | 4,245 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $19,144 | 4,245 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $16,690 | 3,597 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $24,963 | 3,597 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $87,762 | 16,559 | Shares | Defined | 2025-02-28 | |
| 2024-06-30 | $59,102 | 15,803 | Shares | Defined | 2025-05-29 | |
| 2024-03-31 | $111,411 | 15,803 | Shares | Defined | 2025-05-29 | |
| 2023-12-31 | $113,948 | 20,168 | Shares | Defined | 2025-05-29 | |
| 2023-09-30 | $165,853 | 34,625 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $192,867 | 28,156 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $64,025 | 8,219 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $56,602 | 7,438 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $57,630 | 7,054 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $66,954 | 6,924 | Shares | Defined | 2022-08-22 | |
| 2022-03-31 | $70,001 | 4,993 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $67,733 | 3,317 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $24,106 | 1,082 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $68,099 | 3,000 | Shares | Defined | 2021-08-12 | |
| No filing history on record for this holder in this stock. | ||||||